Related Experiment Video
Updated: May 9, 2026
11:49
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Engaging expectant parents to receive Tdap vaccination
Brian Steiner1, Geeta K Swamy1, Emmanuel B Walter1
1School of Medicine, Duke University, Durham, North Carolina.
American Journal of Perinatology
|August 7, 2013
Summary
Tdap vaccination for partners of pregnant women is acceptable, offering "cocooning" protection for infants against pertussis. Implementation requires obstetrician-gynecologist support for widespread adoption.
Area of Science:
- Public Health
- Vaccinology
- Maternal and Child Health
Background:
- Pertussis (whooping cough) poses a significant risk to vulnerable infants.
- Vaccination of pregnant women and their close contacts is a key strategy for infant protection.
- Tdap vaccination offers protection against tetanus, diphtheria, and pertussis.
Purpose of the Study:
- To evaluate the acceptability of a Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination program for partners of pregnant women.
- To determine the feasibility of integrating partner Tdap vaccination into prenatal care settings.
Main Methods:
- A prospective acceptability study enrolled pregnant women and their partners.
- Tdap vaccine was offered to eligible partners during prenatal visits and to eligible pregnant women postpartum.
- Acceptance was defined as receiving the Tdap vaccine during the study period.
Main Results:
- 61.4% of eligible partners accepted Tdap vaccination.
- Partners invited via mail were more likely to accept Tdap (84%) compared to those enrolled initially (44%).
- 65% of eligible pregnant women received Tdap postpartum; demographic factors and beliefs did not influence acceptance.
Conclusions:
- Tdap vaccination for partners during prenatal care is acceptable and feasible.
- Widespread implementation necessitates obstetrician-gynecologist involvement in vaccinating both pregnant women and their partners.
- Such programs enhance "cocooning" strategies to protect infants from pertussis.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:51Vaccinations
Overview
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:25Transmission-based Precautions II: Airborne and Protective Environment
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...